| Literature DB >> 32765063 |
Liang Wang1, Jun Yang1, Jian Huang1, Zheng-Qi Wen1, Ning Xu1, Xuan Liu1, Jian-Hua Zhang2, Wen-Liang Li1.
Abstract
OBJECTIVE: Colorectal cancer (CRC) is one of the most common malignant tumors in the digestive tract, which accounts for 10% of all the malignant tumors in the world. The aim of this study was to identify key genes and miRNAs in CRC diagnosis, prognosis, and therapy and to further explore the potential molecular mechanisms of CRC.Entities:
Keywords: N2 phenotype neutrophils; colorectal cancer; miRNA
Year: 2020 PMID: 32765063 PMCID: PMC7368334 DOI: 10.2147/CMAR.S251427
Source DB: PubMed Journal: Cancer Manag Res ISSN: 1179-1322 Impact factor: 3.989
Figure 1Heat map generated by hierarchical clustering of differentially expressed miRNAs in neutrophil and N2 neutrophil samples. (A) Group 1: neutrophi samples, (B) Group 2: N2 neutrophil samples, the highly-expressed and lowly-expressed miRNAs are represented in red and green respectively.
Figure 2Representative immunohistochemical images (A) and IOD analysis (B) of neutrophil infiltration in primary colorectal cancer and paracancerous tissues. Both CD66b, CD11b and mmp9 showed positive staining (arrows).*P < 0.05.
Deferential Expression miRNA (Based on Raw p-value)
| Systematic_Name | Mirbase Accession | Raw p | BH-FDR | MeanM |
|---|---|---|---|---|
| hsa-miR-3938 | MIMAT0018353 | 0 | 0 | −5.312 |
| hsa-miR-4780 | MIMAT0019939 | 0 | 0.001 | 5.171 |
| hsa-miR-513b-3p | MIMAT0026749 | 0.002 | 0.965 | 0.672 |
| hsa-miR-5703 | MIMAT0022496 | 0.008 | 0.965 | 0.437 |
| hsa-miR-630 | MIMAT0003299 | 0.012 | 0.965 | 0.413 |
| hsa-miR-6089 | MIMAT0023714 | 0.015 | 0.965 | −0.306 |
| hsa-miR-4684-3p | MIMAT0019770 | 0.018 | 0.965 | 0.552 |
| hsa-miR-2114-3p | MIMAT0011157 | 0.021 | 0.965 | −0.492 |
| hsa-miR-1301-5p | MIMAT0026639 | 0.022 | 0.965 | −0.281 |
| hsa-miR-6736-3p | MIMAT0027374 | 0.022 | 0.965 | 0.379 |
| hsa-miR-1307-3p | MIMAT0005951 | 0.024 | 0.965 | −0.606 |
| hsa-miR-5010-5p | MIMAT0021043 | 0.027 | 0.965 | −0.392 |
| hsa-miR-4439 | MIMAT0018957 | 0.028 | 0.965 | −0.411 |
| hsa-miR-3196 | MIMAT0015080 | 0.029 | 0.965 | −0.4 |
| hsa-miR-5694 | MIMAT0022487 | 0.035 | 0.965 | −0.621 |
| hsa-miR-1273g-5p | MIMAT0020602 | 0.035 | 0.965 | −3.713 |
| hsa-miR-5587-5p | MIMAT0022289 | 0.035 | 0.965 | −3.713 |
| hsa-miR-7159-5p | MIMAT0028228 | 0.036 | 0.965 | −0.38 |
| hsa-miR-4738-3p | MIMAT0019867 | 0.036 | 0.965 | 0.266 |
| hsa-miR-6754-5p | MIMAT0027408 | 0.037 | 0.965 | 0.278 |
| hsa-miR-3928-5p | MIMAT0027037 | 0.037 | 0.965 | −0.453 |
| hsa-miR-4754 | MIMAT0019894 | 0.037 | 0.965 | 0.381 |
| hsa-miR-3151-5p | MIMAT0015024 | 0.038 | 0.965 | −0.544 |
| hsa-miR-6125 | MIMAT0024598 | 0.039 | 0.965 | −0.265 |
| hsa-miR-6818-5p | MIMAT0027536 | 0.04 | 0.965 | −0.675 |
| hsa-miR-615-3p | MIMAT0003283 | 0.041 | 0.965 | 0.564 |
| hsa-miR-4730 | MIMAT0019852 | 0.042 | 0.965 | −0.905 |
| hsa-miR-8060 | MIMAT0030987 | 0.042 | 0.965 | 0.288 |
| hsa-miR-5588-3p | MIMAT0022296 | 0.045 | 0.965 | 0.348 |
| hsa-miR-4421 | MIMAT0018934 | 0.045 | 0.965 | 0.561 |
| hsa-miR-3136-5p | MIMAT0015003 | 0.046 | 0.965 | 0.318 |
| hsa-miR-627-5p | MIMAT0003296 | 0.048 | 0.965 | 0.338 |
| hsa-miR-6836-3p | MIMAT0027575 | 0.048 | 0.965 | −0.225 |
Notes: Raw p, raw p value; BH-FDR, adjusted false discovery rate (FDR) using Benjamin & Hochberg method; meanM, the different normalized value between Test group and Control group (neutrophil+TGF-β1 group minus neutrophil group).
Figure 3The box plot shows the enrichment of total miRNAs in each sample. Box plot was used for intuitive analysis and comparison of the average level and degree of variation of multiple sets of data, and was a convenient method for quickly observing the data distribution. The y-axis shows the total miRNA enrichment as the log2-ratio. In the resulting profile, all enrichment > 0 are shown.
Figure 4The volcano plot and Scatter Plot. (A) The volcano plot represented the differentially expressed miRNAs with statistical significance; (B) Scatter plot illustrated the normalized circRNA expression in both groups. The x-axis represented the miRNA level in neutrophil group, the y-axis represented the miRNA level in N2 neutrophil group. In the volcano plot and Scatter Plot, the up-regulated miRNAs were represented as the red dots, while the down-regulated miRNAs were represented as the green dots.
Figure 5Gene Ontology and KEGG Pathway enrichment for the host genes encoding DEmiRNAs.
Figure 6The predicted downstream miRNA-targets network of the validated DEmiRNAs.
DEmRNAs Target Genes
| miRNA | Target | N |
|---|---|---|
| hsa-miR-3938 | AMOT,ANGPTL5,ANKRD54,ARCN1,ASAH2,ATP6V0A2,BCL10,BORA,BRWD1,CCDC141,CCDC169,CCDC73,CCSAP,CDC73,CDRT4,CPOX,CTPS2,DAZL,DDTL,DECR1,DLD,EIF2AK2,FAM216B,FARP1,FAT3,FBXO38,FGF18,GCNT2,GCSAM,GPR155,IL17RB,ISM1,KAT2A,KDELC2,KIAA1755,LAX1,LPIN3,LRP2,MIB1,MITD1,MRPS34,MTMR12,MTMR7,MYH15,NANP,NUDT15,PDHX,PNISR,PWWP2A,RELL1,RNF121,RP11-362K2.2,SLC16A1,SLC16A14,SLC16A7,SLC17A4,SLC35E4,SNX4,SS18,ST8SIA4,SYTL5,TLDC1,TMEM206,TMEM237,TMEM75,TOMM22,TROVE2,TSPAN31, | 80 |
| hsa-miR-4780 | AMIGO1,ANGEL2,AP3M2,ARHGAP31,ARHGAP6,ATG13,ATXN7,BAIAP2L1,BBIP1,BBS7,C6orf120,CD163,CFHR3,CIPC,CLNK,COBLL1,COL21A1,COL24A1,COL6A6,COQ3,CRHBP,DCLK1,DDX3Y,DEPDC1B,DLEU2L,DLGAP5,ENOX2,EPM2AIP1,ERBB2IP,FUT10,GFOD1,GPR126,HELZ,HEXIM1,HNMT,IGSF23,IL6ST,ILDR2,ITGAV,KCNJ14,KLF3,LCN10,LL0XNC01-19D8.1,LSM11,MCEMP1,MED14,MEGT1,MFAP5,MFSD11,MMP13,MMRN2,MPP1,MTERF,MTHFD2L,MVK,NAPEPLD,NCALD,NR1I3,OR5AU1,PARL,PGBD5,PID1,PKM,POLD3,PRDM7,PRIMA1,PRR34,PSMD14,PTBP3,PTGDR,PTPRD,ROCK1,RP11-296A16.1,SCML1,SERINC4,SLC25A29,SMIM3,SREK1,SRPX2,SRSF12,SUV39H2,SVIL,TCP11X2,TMEM132C,TMEM156,TMEM246,TMTC3,TOMM40L,TRMT13,TUBB, | 101 |
Notes: The genes were regulated by hsa-mir-3938 and hsa-mir-4780 were listed in the table and were bold.
Figure 7The expression levels of DEmiRNA, TUSC1 and ZNF197. (A) The expression levels of hsa-miR-3938 in neutrophil group and neutrophil+TGF-β1 group; (B) The expression levels of hsa-miR-4780 in neutrophil group and neutrophil+TGF-β1 group; (C) The expression levels of TUSC1 and ZNF197 in neutrophil group and neutrophil+TGF-β1 group.
Figure 8(A) The effects of hsa-mir-3938 and hsa-mir-4780 on expression of TUSC1; (B) The effects of hsa-mir-3938 and hsa-mir-4780 on expression of ZNF197. ***P < 0.001.
List of Abbreviations
| Abbreviations | |
|---|---|
| Acute promyelocytic leukemia | APL |
| All-trans retinoic acid | ATRA |
| Biological process | BP |
| Cellular component | CC |
| Colorectal cancer | CRC |
| Epithelial to mesenchymal transition | EMT |
| Gene Ontology | GO |
| Glyceraldehyde 3-phosphate dehydrogenase | GAPDH |
| Kruppel-associated box | KRAB |
| Kyoto Encyclopedia of Genes and Genomes | KEGG |
| Long non-coding RNAs | lncRNAs |
| Matrix metalloproteinase-9 | MMP9 |
| Messenger RNAs | mRNAs |
| MircRNAs | miRNAs |
| Molecular function | MF |
| Real-time polymerase chain reaction | RT-PCR |
| Transforming growth factor-β1 | TGF-β1 |
| Tumor-associated neutrophils | TANs |
| Tumor infiltrating neutrophils | TINs |
| Tumor suppressor candidate 1 | TUSC1 |
| Zinc finger protein 197 | ZNF197 |